Gogebic Medical Care Facility Medicare and Medicaid Location: 402 North Street, Wakefield, Michigan 49968 Ratings: Phone: (906) 224-9811 |
News Archive
In studies on rats, Johns Hopkins Medicine scientists report new evidence that the predominance of the hormone testosterone in males may explain why women are up to 10 times more likely than men to injure the anterior cruciate ligament (ACL) in their knees.
Bruin Biometrics, LLC has been granted U.S. Food and Drug Administration marketing authorization for the SEM Scanner, becoming the world's first FDA-authorised device to objectively alert clinicians to specific anatomical areas of a patient's body at increased risk for developing pressure damage.
UBM Medica's widely acclaimed and trusted cancer care reference book Cancer Management: A Multidisciplinary Approach, 14th edition, is now available online. This guide is designed to present important clinical information concisely, uniformly, and logically, emphasizing the natural history of the malignancy, screening and diagnosis, staging and prognosis, and treatment of cancers.
The introduction of minimally invasive transcatheter aortic valve replacement (TAVR) for treatment of aortic stenos not only has increased the number of patients eligible for aortic valve replacement (AVR), but also has led to a decrease in patient mortality, according to a study released today at the 50th Annual Meeting of The Society of Thoracic Surgeons.
INSIGHTEC announced today that Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Mississippi, Wellmark Blue Cross Blue Shield, Blue Cross of Idaho and Blue Cross Blue Shield of Arizona have published an updated coverage policy regarding INSIGHTEC's ExAblate MRgFUS (Magnetic Resonance Imaging-guided Focused Ultrasound) procedure which provides benefits for bone metastases patients. The ExAblate treatment is FDA-approved for patients suffering from pain associated with bone metastases.
› Verified 8 days ago